|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 |
| (11) | Patento numeris | 3405212 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17702951.9 |
| Europos patento paraiškos padavimo data | 2017-01-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/050229 |
| Data | 2017-01-16 |
| (87) | Numeris | WO 2017/125844 |
| Data | 2017-07-27 |
| (30) | Numeris | Data | Šalis |
| 201662280636 P | 2016-01-19 | US | |
| 201662419190 P | 2016-11-08 | US |
| (72) |
BINDER, Joseph John, US
CHO, Helen Kim, US
COCKLE, Paul Jason, US
FALCONER, Derek John, US
GURU, Siradanahalli, US
JOOSS, Karin Ute, US
MARTINIC, Marianne Marcela Andrea, US
WILLS, Kenneth Nelson, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CANCER VACCINES |
| CANCER VACCINES |